Literature DB >> 18160087

Comparative evaluation of direct agglutination test, rK39 and soluble antigen ELISA and IFAT for the diagnosis of visceral leishmaniasis.

Mariana Junqueira Pedras1, Luciana de Gouvêa Viana, Edward José de Oliveira, Ana Rabello.   

Abstract

Five serological tests for the diagnosis of visceral leishmaniasis (VL) were compared: a direct agglutination test (DAT) based on freeze-dried antigen (DAT-fd); a locally produced DAT (DAT-LPC); an IgG ELISA against rK39 (ELISA-rK39); an IgG ELISA for Leishmania chagasi (ELISA-L. chagasi); and an IgG IFAT against L. chagasi. Serum samples from 88 patients with VL, 20 non-infected individuals and 85 patients with others infectious diseases were evaluated. The sensitivity rates were: DAT-fd, 96.6%; DAT-LPC, 95.5%; ELISA-rK39, 88.6%; ELISA-L. chagasi, 89.8%; and IFAT, 92.0% (P>0.05). The specificity for the control groups varied from 53.3% to 100%. DAT-fd had the highest efficiency (97.4%), followed by DAT-LPC (91.7%) and ELISA-rK39 (90.7%). Our data suggest that DAT-fd, DAT-LPC and ELISA-rK39 are useful tests for the diagnosis of VL and could replace IFAT as the routine diagnostic test in Brazil.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 18160087     DOI: 10.1016/j.trstmh.2007.11.004

Source DB:  PubMed          Journal:  Trans R Soc Trop Med Hyg        ISSN: 0035-9203            Impact factor:   2.184


  21 in total

1.  Characterization of novel Leishmania infantum recombinant proteins encoded by genes from five families with distinct capacities for serodiagnosis of canine and human visceral leishmaniasis.

Authors:  Geraldo G S Oliveira; Franklin B Magalhães; Márcia C A Teixeira; Andrea M Pereira; Cristiane G M Pinheiro; Lenita R Santos; Marília B Nascimento; Cheila N G Bedor; Alessandra L Albuquerque; Washington L C dos-Santos; Yara M Gomes; Edson D Moreira; Maria E F Brito; Lain C Pontes de Carvalho; Osvaldo P de Melo Neto
Journal:  Am J Trop Med Hyg       Date:  2011-12       Impact factor: 2.345

2.  Evaluation of two rK39 dipstick tests, direct agglutination test, and indirect fluorescent antibody test for diagnosis of visceral leishmaniasis in a new epidemic site in highland Ethiopia.

Authors:  Carmen Cañavate; Merce Herrero; Javier Nieto; Israel Cruz; Carmen Chicharro; Pilar Aparicio; Abate Mulugeta; Daniel Argaw; Anna J Blackstock; Jorge Alvar; Caryn Bern
Journal:  Am J Trop Med Hyg       Date:  2011-01       Impact factor: 2.345

3.  Alteration of the serum biomarker profiles of visceral leishmaniasis during treatment.

Authors:  M S Duthie; J Guderian; A Vallur; A Bhatia; P Lima dos Santos; E Vieira de Melo; A Ribeiro de Jesus; M Todt; D Mondal; R Almeida; S G Reed
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2013-10-31       Impact factor: 3.267

4.  Evaluation of rK-39 strip test using urine for diagnosis of visceral leishmaniasis in an endemic region of India.

Authors:  Dharmendra Singh; Krishna Pandey; Vidya Nand Rabi Das; Sushmita Das; Neena Verma; Alok Ranjan; Sekhar Chandra Lal; Kamal Roshan Topno; Shubhankar Kumar Singh; Rakesh Bihari Verma; Ashish Kumar; Abul Hasan Sardar; Bidyut Purkait; Pradeep Das
Journal:  Am J Trop Med Hyg       Date:  2012-11-13       Impact factor: 2.345

5.  Comparison of parasitological, serological, and molecular tests for visceral leishmaniasis in HIV-infected patients: a cross-sectional delayed-type study.

Authors:  Gláucia Fernandes Cota; Marcos Roberto de Sousa; Betânia Mara de Freitas Nogueira; Luciana Inácia Gomes; Edward Oliveira; Tália Santana Machado Assis; Andréa Laender Pessoa de Mendonça; Bruna Fernandes Pinto; Juliana Wilke Saliba; Ana Rabello
Journal:  Am J Trop Med Hyg       Date:  2013-07-08       Impact factor: 2.345

6.  Performance of rK39 immunochromatography and freeze-dried direct agglutination tests in the diagnosis of imported visceral leishmaniasis.

Authors:  Amal El-Moamly; Mohamed El-Sweify; Mohamed Hafeez
Journal:  Parasitol Res       Date:  2011-06-28       Impact factor: 2.289

7.  Design, development and evaluation of rK28-based point-of-care tests for improving rapid diagnosis of visceral leishmaniasis.

Authors:  Sowmya Pattabhi; Jacqueline Whittle; Raodoh Mohamath; Sayda El-Safi; Garner G Moulton; Jeffrey A Guderian; Danny Colombara; Asem O Abdoon; Maowia M Mukhtar; Dinesh Mondal; Javan Esfandiari; Shailendra Kumar; Peter Chun; Steven G Reed; Ajay Bhatia
Journal:  PLoS Negl Trop Dis       Date:  2010-09-14

8.  Antigenemia in patients with mediterranean visceral leishmaniasis.

Authors:  Bernard Ferrua; Nicolas Rol; Grégory Michel; Pierre Marty
Journal:  J Clin Microbiol       Date:  2009-09-16       Impact factor: 5.948

9.  Cellular and humoral responses to Leishmania major virulence factors in healed cutaneous leishmaniasis and Mediterranean visceral leishmaniasis patients.

Authors:  Inès Lakhal-Naouar; Thouraya Boussoffara; Amel Meddeb-Garnaoui; Yosser Ben Achour-Chenik; Hechmi Louzir; Mehdi Chenik
Journal:  Clin Vaccine Immunol       Date:  2009-04-01

Review 10.  Control of visceral leishmaniasis in latin america-a systematic review.

Authors:  Gustavo A S Romero; Marleen Boelaert
Journal:  PLoS Negl Trop Dis       Date:  2010-01-19
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.